10x Genomics, Inc. is trading 8% down at $30.83 on profit-taking and mean reversion following a rapid multi-day rebound.
- Shares had surged approximately one-third from late May through June 4 before the current pullback.
- The decline appears driven by a broader risk-off sentiment for growth stocks rather than company-specific news.
- No new negative developments or changes to guidance have been reported by the company.